Artal Group S.A. Molecular Partners Ag Transaction History
Artal Group S.A.
- $1.86 Billion
- Q1 2024
Shares
2 transactions
Others Institutions Holding MOLN
# of Institutions
9Shares Held
946KCall Options Held
0Put Options Held
0-
Bvf Inc San Francisco, CA443KShares$3.2 Million0.06% of portfolio
-
Suvretta Capital Management, LLC New York, NY400KShares$2.89 Million0.07% of portfolio
-
Tang Capital Management LLC San Diego, CA100KShares$723,0000.05% of portfolio
-
Royal Bank Of Canada Toronto, A61.5KShares$10,8450.0% of portfolio
-
Morgan Stanley New York, NY367Shares$2,6530.0% of portfolio
About MOLECULAR PARTNERS AG
- Ticker MOLN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 32,514,000
- Market Cap $235M
- Description
- Molecular Partners AG operates as a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic proteins. Its products candidates include Abicipar, a DARPin therapeutic candidate, which is in Phase III clinical trials for the treatment of neovascular wet age-related macular degeneration, ...